Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adavosertib and irinotecan in pediatric relapsed or refractory solid tumors
NCT02095132Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Mar 2014
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of adavosertib in solid tumor, neuroblastoma, medulloblastoma, rhabdomyosarcoma (RMS), central nervous system embryonal tumor, sponsored by National Cancer Institute. Started Mar 2014; status: completed.
02
Drugs
adavosertib
03
Conditions
solid tumorneuroblastomamedulloblastomarhabdomyosarcoma (RMS)central nervous system embryonal tumor
Beyond the preview
Go deeper on NCT02095132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02095132.